Senti Biosciences
SNTI
SNTI
28 hedge funds and large institutions have $7.64M invested in Senti Biosciences in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.09% less ownership
Funds ownership: 2.85% → 2.76% (-0.09%)
46% less capital invested
Capital invested by funds: $14.3M → $7.64M (-$6.62M)
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$56.2K | |
| 2 | +$31.2K | |
| 3 | +$23.7K | |
| 4 |
VF
Virtu Financial
New York
|
+$22K |
| 5 |
Renaissance Technologies
New York
|
+$11K |
Top Sellers
| 1 | -$172K | |
| 2 | -$146K | |
| 3 | -$46.5K | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$44.9K |
| 5 |
Citigroup
New York
|
-$17.1K |